The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Effect of Antisense Hypoxia-inducible Factor 1?? on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer
Abstract
OBJECTIVES: The aim of the study was to observe the effect of antisense hypoxia-inducible factor 1alpha (HIF-1alpha) on progression, metastasis, and chemosensitivity of pancreatic cancer. METHODS: BxPc-3 cells transfected with antisense HIF-1alpha plasmid were exposed to 0.5% O2 for 4 hours. Expressions of HIF-1alpha, survivin, and beta1 integrin were detected by reverse transcriptase -polymerase chain reaction and Western blotting. Growth inhibition rates and apoptosis rates of BxPc-3 cells under different dosages of chemotherapy agents (5-fluorouracil, doxorubicin, and gemcitabine) were measured by MTT colorimetric assay and flow cytometry. The migration of BxPc-3 cells was assayed using transwell cell culture chambers. Subcutaneous transplantation of BxPc-3 cells in nude mice for 8 weeks was to assess progression and metastasis of pancreatic cancer. RESULTS: Expression of HIF-1alpha was obviously down-regulated, and at the same time, survivin and beta1-integrin expressions were markedly down-regulated in the experimental group (P < 0.05). Higher dosages (100, 200, and 400 mg/L of 5-fluorouracil; 0.05, 0.075, and 0.1 mg/L of doxorubicin; and 10(-9), 10(-8), and 10(-7) mol/L of gemcitabine) caused a greater increase of inhibition in the experimental group than in control (P < 0.05). The number of migrated BxPc-3 cells in the experimental group was far less than in control (P < 0.05). In vivo, the tumor size and weight in the experimental group were significantly lower than those in control (P < 0.05). CONCLUSION: Our data demonstrate that antisense HIF-1alpha inhibits expressions of survivin and beta1 integrin, enhancing apoptosis in human pancreatic cancer cells and restraining the progression and metastasis of pancreatic cancer. Therefore, HIF-1alpha may play a very important role in progression, metastasis, and chemosensitivity of human pancreatic cancer. Blocking HIF-1alpha in pancreatic cancer cells may offer an avenue for gene therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, decreasing HIF transcriptional activity through antisense, dominant-negative, or short interfering RNA constructs (12, 14, 27, 30, 39) slows tumor progression.”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [12]
Citations
Cites
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213 · cited 1×
“Whereas HIF-1A is a common subunit of multiple bHLH proteins, HIF-1> is the unique, O2-regulated subunit that determines HIF-1 activity.(1) Although HIF-1A is quite stable in normoxic conditions, HIF-1> is extremely unstable and quickly degraded by the ubiquitin-proteasome system.”
BackgroundRegulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki, H., Altieri, D. C., Lu, C., Toyoda, M., Tenjo, T., & Tanigawa, N. (1998) · PubMed · Cited by 706
(2000) · PubMed · Cited by 614
Research works printed but not linked: 15
- Tamm, 1998, Cancer Res, 58, 5315
- Kawasaki, 1998, Cancer Res, 58, 5071
- Lu, 1998, Cancer Res, 58, 1808
- Tanaka, 2000, Clin Cancer Res, 6, 127
- Altieri, 1999, Lab Invest, 79, 1327
- Olie, 2000, Cancer Res, 60, 2805
- Yang, 2003, Cancer Res, 63, 8312
- Akakura, 2001, Cancer Res, 61, 6548
- Shibaji, 2003, Anticancer Res, 23, 4721
- Altieri, 2003, Methods Mol Biol, 223, 533
- Chen, 2003, Chin J Med, 83, 425
- Wei, 2005, Ai Zheng, 24, 184
- Zhong, 1998, Cancer Res, 58, 5280
- Birner, 2000, Cancer Res, 60, 4693
- Volm, 2000, Anticancer Res, 20, 3449
Cited by
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Ziello, J. E., Jovin, I. S., & Huang, Y. (2007) · PubMed Central · Cited by 895
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608
Role of hypoxia in the hallmarks of human cancer
Ruan, K., Song, G., & Ouyang, G. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22214 · Cited by 489
“One report revealed that antisense HIF-1a treatment can inhibit the expression of survivin and b1 integrin, enhance apoptosis in human pancreatic cancer cells, and restrain the invasion and metastasis of pancreatic cancer [Chang et al., 2006].”
BackgroundGuzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427
“Conversely, decreasing HIF transcriptional activity through antisense, dominant-negative, or short interfering RNA constructs ( 12 , 14, 27, 30, 39) slows tumor progression.”
Background
Metadata
- Authors
- Chang, Q., Qin, R., Huang, T., Gao, J., & Feng, Y.
- Affiliations
- Tongji Hospital (CN)
- Venue
- Pancreas
- Published
- 2006-04
- Volume
- 32
- Issue
- 3
- Pages
- 297-305
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2017978798
- Cited by
- 57
- References
- 69
- Citations by year
- 2025: 1 · 2019: 2 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 3 · 2012: 5
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pancreas (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia-inducible factor-1α, antisense gene therapy, pancreatic cancer, metastasis, tumor progression, chemosensitivity, survivin, beta1 integrin, apoptosis, cell migration, 5-fluorouracil, doxorubicin, gemcitabine, BxPC-3 cells, tumor growth inhibition, hypoxia, gene knockdown
- MeSH terms
- Survivin, Animals, Cell Movement, Colorimetry, Flow Cytometry, Humans, Male, Mice, Inbred BALB C, Mice, Nude, Microtubule-Associated Proteins, Neoplasm Metastasis, Neoplasm Proteins, Neoplasm Transplantation, Pancreatic Neoplasms, Transplantation, Heterologous, Genetic Therapy, Antisense Elements (Genetics), Apoptosis, Disease Progression, Integrin beta1, Cell Line, Tumor, Inhibitor of Apoptosis Proteins, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Antisense Hypoxia-inducible Factor 1?? on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer. https://app.cochat.ai/papers/10.1097/00006676-200604000-00010
- The paper
- Chang, Q., Qin, R., Huang, T., Gao, J., & Feng, Y. (2006). Effect of Antisense Hypoxia-inducible Factor 1?? on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer. Pancreas. https://doi.org/10.1097/00006676-200604000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.